These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 191950)

  • 1. Effect of thrombin and ADP on a membrane bound cyclic AMP dependent kinase of human platelets. Studies on normal platelets and those from patients with Von Willebrand's disease.
    Smith D; Damus PS
    Thromb Res; 1977 Feb; 10(2):301-8. PubMed ID: 191950
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet von Willebrand's antigen II: active release by aggregating agents and a marker of platelet release reaction in vivo.
    Scott JP; Montgomery RR
    Blood; 1981 Dec; 58(6):1075-80. PubMed ID: 6975640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic adenosine 3',5'-monophosphate dependent protein kinase of human platelets: membrane phosphorylation and regulation of platelet function.
    Booyse FM; Guiliani D; Marr JJ; Rafelson ME
    Ser Haematol; 1973; 6(3):351-66. PubMed ID: 4360128
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary giant platelet syndrome: a disorder of a new aspect of platelet function.
    Howard MA; Hutton RA; Hardisty RM
    Br Med J; 1973 Jun; 2(5866):586-8. PubMed ID: 4541347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand's disease, platelet-release defect and angiodysplasia.
    Rosborough TK; Swaim WR
    Am J Med; 1978 Jul; 65(1):96-100. PubMed ID: 308316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active release of human platelet factor VIII-related antigen by adenosine diphosphate, collagen, and thrombin.
    Koutts J; Walsh PN; Plow EF; Fenton JW; Bouma BN; Zimmerman TS
    J Clin Invest; 1978 Dec; 62(6):1255-63. PubMed ID: 311783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid differentiation of type IIb von Willebrand's disease from platelet-type (pseudo-) von Willebrand's disease by the "neutral" monoclonal antibody binding assay.
    Scott JP; Montgomery RR
    Am J Clin Pathol; 1991 Dec; 96(6):723-8. PubMed ID: 1746488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
    López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
    Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibronectin modulates the activation of human platelets.
    Sinigaglia F; Torti M; Ramaschi G; Balduini C
    Biochem Biophys Res Commun; 1989 Dec; 165(3):966-72. PubMed ID: 2558659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin in von Willebrand's disease and thrombasthenia: role in platelet aggregation.
    Cohen I; Potter EV; Glaser T; Entwistle R; Davis L; Chediak J; Anderson B
    J Lab Clin Med; 1981 Jan; 97(1):134-40. PubMed ID: 6969768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of calcium, thrombin and nucleotides (ADP, cAMP, cGMP) on blood platelet glycolysis and energy metabolism].
    Nikulin AA
    Farmakol Toksikol; 1980; 43(5):585-90. PubMed ID: 6256208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic AMP in human blood platelets: relation to platelet prostaglandin synthesis induced by centrifugation or surface contact.
    Salzman EW; Lindon JN; Rodvien R
    J Cyclic Nucleotide Res; 1976; 2(1):25-37. PubMed ID: 178701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic 3',5'-adenosine monophosphate in human blood platelets. 3. The role of cyclic AMP in platelet aggregation.
    Salzman EW; Rubino EB; Sims RV
    Ser Haematol; 1970; 3(4):100-13. PubMed ID: 4329913
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of membrane anisotropy with function in subpopulations of human blood platelets.
    Raha S; Opper C; Wesemann W
    Br J Haematol; 1989 Jul; 72(3):397-401. PubMed ID: 2548563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanism of platelet adhesion.
    Hardisty RM
    Adv Exp Med Biol; 1985; 192():411-8. PubMed ID: 2422888
    [No Abstract]   [Full Text] [Related]  

  • 20. ADP-INDUCED PLATELET ADHESIVENESS AS A DIAGNOSTIC TEST IN VON WILLEBRAND'S DISEASE.
    ODEGAARD AE; HELLEM AJ
    Thromb Diath Haemorrh; 1964 Apr; 11():23-6. PubMed ID: 14167108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.